Cargando…
Convection-Enhanced Delivery of a First-in-Class Anti-β1 Integrin Antibody for the Treatment of High-Grade Glioma Utilizing Real-Time Imaging
Introduction: OS2966 is a first-in-class, humanized and de-immunized monoclonal antibody which targets the adhesion receptor subunit, CD29/β1 integrin. CD29 expression is highly upregulated in glioblastoma and has been shown to drive tumor progression, invasion, and resistance to multiple modalities...
Autores principales: | Nwagwu, Chibueze D., Immidisetti, Amanda V., Bukanowska, Gabriela, Vogelbaum, Michael A., Carbonell, Anne-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823464/ https://www.ncbi.nlm.nih.gov/pubmed/33396712 http://dx.doi.org/10.3390/pharmaceutics13010040 |
Ejemplares similares
-
Convection Enhanced Delivery in the Setting of High-Grade Gliomas
por: Nwagwu, Chibueze D., et al.
Publicado: (2021) -
Clinically Explored Virus-Based Therapies for the Treatment of Recurrent High-Grade Glioma in Adults
por: Immidisetti, Amanda V., et al.
Publicado: (2021) -
Convection-enhanced drug delivery for gliomas
por: Healy, Andrew T., et al.
Publicado: (2015) -
FSMP-05. KETOGENIC DIETS FOR HIGH-GRADE GLIOMA
por: Immidisetti, Amanda, et al.
Publicado: (2021) -
COVD-18. POTENTIAL TO HARNESS SARS-COV-2 NEUROTROPISM IN THE DELIVERY OF ONCOLYTIC VIROTHERAPY FOR THE TREATMENT OF HIGH-GRADE GLIOMA
por: Immidisetti, Amanda, et al.
Publicado: (2020)